Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04748302 · ClinicalTrials.gov registry record
Impaired Glucose Tolerance and Cognition in MS
A clinical trial, sponsored by University of Virginia.
- Terminated
- Registry status
- 7
- Enrollment target
NCT04748302: Clinical Trial study, sponsored by University of Virginia.
NCT04748302 is a clinical trial that was terminated before completion, run by University of Virginia. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04748302 was terminated before completion, sponsored by University of Virginia.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This is a pilot study to compare cognitive performance in two groups of subjects with multiple sclerosis; those with normal glucose tolerance and those with impaired glucose tolerance. The study consists of a 2 hour oral glucose tolerance test, patient reported outcomes, a series of cognitive functioning tests, and outpatient physical assessment using a pedometer.
Primary Outcome
The expanded disability scale (EDSS) will be used to determine a subjects level of disability. This value will then be compared to the subjects category of glucose intolerance, measured by yes (abnormal glucose tolerance) or no (normal glucose tolerance). This is on a score from 0 (no disability) to 8 (bedridden)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2020-04-01 |
Why NCT04748302 stopped before completion
NCT04748302 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04748302 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04748302 about?
NCT04748302 is a clinical study titled "Impaired Glucose Tolerance and Cognition in MS". This is a pilot study to compare cognitive performance in two groups of subjects with multiple sclerosis; those with normal glucose tolerance and those with impaired glucose tolerance. The study consists of a 2 hour oral glucose tolerance test, patient reported outcomes, a series of cognitive functi...
What is the current status of trial NCT04748302?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2020-01-06. Estimated completion is 2020-04-01.
Who is sponsoring clinical trial NCT04748302?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI